6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Sofgen Pharma S.A.
Filed: April 9, 2025
Period of Report: April 9, 2025
Accession Number: 0001213900-25-030333

View Document ↗ View on SEC.gov ↗